In the prefrontal cortex of Alzheimer’s disease brains, there is decreased activity of PKC and glycogen synthase kinase (GSK) 3β (Tsang et al., 2007; Medeiros et al., 2011). This evidence concerns the gene PRRT2 and Alzheimer disease.